Dr. Pluard’s research focuses on novel therapies in metastatic breast cancer. He is Medical Director at Luke’s Cancer Institute and Founding Director of Saint Luke’s Koontz Center for Advanced Breast Cancer, Kansas City. Previously, he was Associate Professor of Medicine and Clinical Director of Breast Oncology at Washington University Siteman Cancer Center, St. Louis. His clinical focus is exclusively metastatic breast cancer care including advanced genomic and immunotherapy treatments, and he is a major contributor to numerous clinical trials. Saint Luke’s Cancer Institute has the region’s largest portfolio of Stage 4 breast cancer clinical trials―through partnerships, access to >200 trials.